98%
921
2 minutes
20
Introduction: Bloodstream infections caused by methicillin-resistant (MRSA) remain a major challenge in most countries worldwide.
Setting: We describe a quasi-experimental sequential intervention at Mater Dei Hospital, Malta, to reduce hyper-prevalence of healthcare-associated MRSA bacteremia (HA-MRSA-B).
Interventions: The hospital initiated a hand hygiene (HH) campaign in 2008 to improve alcohol hand rub (AHR) use. In 2011, this was followed by root cause analysis (RCA) of all HA-MRSA-B cases and finally universal MRSA admission screening in 2014. Change-point analysis was used to evaluate the impact of the interventions.
Results: The effect of the HH campaign became evident when AHR consumption reached 40 L/1000 occupied bed days (BD). RCAs identified intravascular devices as the likely risk factor in 83% of all HA-MRSA-B; specifically non-tunneled double-lumen hemodialysis catheters (36%), peripheral venous cannulas (25%), and central venous catheters (22%). Interventions to improve their management resulted in the greatest reduction of HA-MRSA-B rates. They were informed by the RCA findings and targeted behavior change through education, motivation, and system change. Universal MRSA admission screening provided the final decline in incidence. Each intervention affected HA-MRSA-B rates after a lag period of approximately 18-24 months. Overall, HA-MRSA-B incidence decreased from 1.72 cases/10000BD in 2008 to 0.18/10000BD in 2019; a reduction of almost 90%. Intravenous device interventions were also associated with a reduction of methicillin-sensitive (MSSA) bacteremia rates.
Conclusions: Significant improvement in HA-MRSA-B is possible, even in highly endemic regions. It requires well-planned behavior change interventions which are compatible with local context and culture.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10753512 | PMC |
http://dx.doi.org/10.1017/ash.2023.518 | DOI Listing |
Curr Opin Crit Care
October 2025
Infectious Diseases Unit, Azienda Ospedaliera-Universitaria of Modena, University of Modena and Reggio Emilia, Modena, Italy.
Purpose Of Review: Healthcare-associated infections (HAIs) remain a critical challenge in intensive care units (ICUs) due to the high prevalence of invasive procedures, vulnerable patient populations, and the increasing threat of antimicrobial-resistant organisms (MDROs). This review synthesizes current evidence on infection prevention and control (IPC) strategies in the ICU setting, highlighting recent findings and innovations in this evolving field, particularly in light of the impact of the COVID-19 pandemic.
Recent Findings: The review outlines ten key IPC strategies for ICUs, categorizing them into horizontal (universal) and vertical (pathogen-specific) approaches.
Can Commun Dis Rep
July 2025
Background: Healthcare-associated infections (HAIs) and antimicrobial resistance (AMR) continue to contribute to excess morbidity and mortality among Canadians.
Objective: This report describes epidemiologic and laboratory characteristics and trends of HAIs and AMR, 2019-2023, using surveillance and laboratory data submitted by hospitals to the Canadian Nosocomial Infection Surveillance Program (CNISP) and by provincial and territorial laboratories to the National Microbiology Laboratory.
Methods: Data was collected from 109 Canadian sentinel acute care hospitals between January 1, 2019 and December 31, 2023, for infections (CDI), methicillin-resistant (MRSA) bloodstream infections (BSIs), vancomycin-resistant (VRE) BSIs (specifically and ), carbapenemase-producing (CPE) and carbapenemase-producing (CPA) infections and colonizations and ().
J Hosp Infect
August 2025
University Health, Kansas City Hospital 2301 Holmes Street, Kansas City, MO 64108, USA.
Methicillin-resistant Staphylococcus aureus (MRSA) is a strain of Staphylococcus aureus that poses significant challenges for effective treatment and infection control within healthcare settings. Recent research suggests that the incidence of healthcare-associated MRSA (HA-MRSA) is higher among patients treated in safety-net hospitals when compared to other healthcare settings. This study aimed to identify HA-MRSA transmission patterns across various nursing units of a safety-net hospital.
View Article and Find Full Text PDFIran J Microbiol
August 2025
Department of Biotechnology, Iranian Research Organization for Science and Technology (IROST), Tehran, Iran.
Background And Objectives: significantly contributes to healthcare-associated infections, with biofilm formation causing chronic, antibiotic-resistant cases. Because biofilms show high resistance to conventional antibiotics, endolysins have emerged as a promising alternative for treating antibiotic-resistant, biofilm-associated infections. This study evaluated the effects of four culture media and different incubation times on biofilm formation in methicillin-sensitive (MSSA) and methicillin-resistant (MRSA) strains and assessed the anti-biofilm efficacy of a novel chimeric endolysin called ZAM-CS (catalytic domain of SAL-1 endolysin and binding domain of lysostaphin).
View Article and Find Full Text PDFFront Microbiol
July 2025
Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
Introduction: Biofilm-related Multidrug Resistance (MDR) is a major problem in healthcare-associated infections (HAI). Hospital surface decontamination is essential to ensure the safety of patients and to eliminate the dissemination of MDR pathogens. New eco-friendly decontamination technologies, such as UV-C irradiation, are only gaining popularity now, but their use against the biofilm of common microorganisms causing HAI has not been properly assessed.
View Article and Find Full Text PDF